ARCHIVES

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

This article is from The Cancer Letter archive.

Vol. 33 No. 38 | October 19, 2007

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

NCI To Evaluate Chernobyl Effects On Soviet Health

November 23, 1990

Niederhuber Leads AACI

November 2, 2001

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI

April 22, 1994

Time Spent Sitting Associated With Total Mortality, Study Finds

July 30, 2010